Paper Review Records
All Paper Review Records
26 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
UICC TNM 9th Edition Updates: Malignant Melanoma of Conjunctiva
James D. Brierley; Liesbet J. Van Eycken; Brian O'Sullivan; Meredith Elena Giuliani; Shao Hui Huang; Robert M. VerdijkShow moreShow less
1. Department of Radiation Oncology University of Toronto Toronto Ontario Canada; 2. Belgian Cancer Registry Brussels Belgium; 3. Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de L'universite de Montreal University of Montreal Canada; 4. Department Pathology and Clinical Bioinformatics, Section Ophthalmic Pathology Erasmus MC University Medical Center Rotterdam Rotterdam the NetherlandsShow moreShow less
UICC TNM 9th Edition Updates: Cancers of the Colon and Rectum
James D. Brierley; Liesbet J. Van Eycken; Brian O'Sullivan; Meredith Elena Giuliani; Shao Hui Huang; Qian Shi; Iris Nagtegaal; George J. ChangShow moreShow less
1. Department of Radiation Oncology University of Toronto Toronto Ontario Canada; 2. Belgian Cancer Registry Brussels Belgium; 3. Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l’Universite de Montreal University of Montreal Montreal Quebec Canada; 4. Department of Quantitative Health Sciences Mayo Clinic Rochester Minnesota USA; 5. Department of Pathology Radboud University Medical Centre Nijmegen the Netherlands; 6. Department of Colon & Rectal Surgery, Division of Surgery The University of Texas MD Anderson Cancer Center Houston Texas USAShow moreShow less
Cancer Incidence and Mortality Patterns in Central Asia in 2022 and an Assessment of the Future Burden in 2045
Nino Chkhaberidze; Jerome Vignat; Sayde Djanklich; Elena Ten; Zaure Dushimova; Oxana Shatkovskaya; Sultan Eser; Freddie Bray; Anton Barchuk; Ariana ZnaorShow moreShow less
1. International Agency for Research on Cancer (IARC/WHO), Cancer Surveillance Branch Lyon France; 2. Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology Tashkent Uzbekistan; 3. International Highest School of Medicine Bishkek The Kyrgyz Republic; 4. National Institute of Public Health of the MoH of the Kyrgyz Republic Bishkek The Kyrgyz Republic; 5. Department of Fundamental Medicine Al‐Farabi Kazakh National University Almaty Kazakhstan; 6. National Research Oncology Center Astana Kazakhstan; 7. Medical Faculty University of Health Sciences Izmir TurkeyShow moreShow less
Optimizing Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Risk‐Stratified Recursive Partitioning Analysis Based on 9th Edition Staging
Jieyi Lin; Tianyi Wang; Jiashi Xiao; Jiaying Lin; Ting Liu; Jinjing Lu; Haoyuan Mo; Ruiling Xie; Haiqiang Mai; Qiuyan ChenShow moreShow less
1. State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Nasopharyngeal Carcinoma, Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong People's Republic of China; 2. Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University Guangzhou Guangdong People's Republic of China; 3. Breast Disease Center, the First Affiliated Hospital of Sun Yat‐Sen University Guangzhou People's Republic of ChinaShow moreShow less
Risk Factors for Advanced Serrated Lesions in the Proximal Colon
Allen Mo; Christopher Flynn; Thomas Petrillo; John W. Birk; James J. Grady; Faripour A. Forouhar; Daniel W. RosenbergShow moreShow less
1. Center for Molecular Oncology University of Connecticut School of Medicine Farmington Connecticut USA; 2. Department of Gastroenterology University of Connecticut School of Medicine Farmington Connecticut USA; 3. Department of Public Health Sciences University of Connecticut School of Medicine Farmington Connecticut USA; 4. Department of Pathology University of Connecticut School of Medicine Farmington Connecticut USAShow moreShow less
Comments on “Concomitant Use of Proton Pump Inhibitors and Survival Outcomes in Patients Receiving Adjuvant Chemotherapy for Stage III Colon Cancer”
Xiaoxiang Zhang; Yu ZhangShow moreShow less
1. Department of Gastrointestinal Surgery Xianju People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital; Affiliated Hospital of Hangzhou Medical College Xianju Zhejiang ChinaShow moreShow less
FAQ
How long does INTERNATIONAL JOURNAL OF CANCER take to review a manuscript?
As of 2026-11-17, CrushSCI has 26 complete review records for INTERNATIONAL JOURNAL OF CANCER. The fastest paper went from submission to acceptance in 10 days (Leveraging Minimal Variables for Maximal Screening Yield: A Global Equity Perspective on Colorectal Cancer Risk Stratification, received 2026-06-09, accepted 2026-06-19); the slowest took 440 days. The average is 147.0 days and the median is 153.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
